Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Short-term Investments (2018 - 2025)

Historic Short-term Investments for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $62000.0.

  • ImmunoTech's Short-term Investments fell 9901.38% to $62000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $62000.0, marking a year-over-year decrease of 9901.38%. This contributed to the annual value of $2.3 million for FY2024, which is 7017.43% down from last year.
  • Per ImmunoTech's latest filing, its Short-term Investments stood at $62000.0 for Q3 2025, which was down 9901.38% from $359000.0 recorded in Q2 2025.
  • Over the past 5 years, ImmunoTech's Short-term Investments peaked at $7.6 million during Q1 2024, and registered a low of $62000.0 during Q3 2025.
  • In the last 3 years, ImmunoTech's Short-term Investments had a median value of $6.4 million in 2024 and averaged $4.7 million.
  • In the last 5 years, ImmunoTech's Short-term Investments plummeted by 1158.97% in 2024 and then plummeted by 9901.38% in 2025.
  • Over the past 3 years, ImmunoTech's Short-term Investments (Quarter) stood at $7.6 million in 2023, then crashed by 70.17% to $2.3 million in 2024, then crashed by 97.28% to $62000.0 in 2025.
  • Its last three reported values are $62000.0 in Q3 2025, $359000.0 for Q2 2025, and $1.3 million during Q1 2025.